Table 4. TCGA univariable and multivariable Cox regression analysis.
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age at diagnosis (≥60 vs. <60) | 1.563 (1.166–2.096) | 0.003* | 1.199(0.839–1.714) | 0.319 |
T stage (T3 + T4 vs. T1 + T2) | 0.443(0 .316-0.622) | <0.000* | 0.825(0.468–1.456) | 0.507 |
N stage (N1–2 vs. N0) | 0.517(0.380–0.703) | <0.000* | 0.246(0.087–0.699) | 0.008* |
M stage (M1 vs. M0) | 0.554(0.292–1.051) | 0.071 | 0.616(0.218–1.741) | 0.361 |
Clinical stage (III + IV vs. I + II) | 0.543(0.399–0.738) | <0.000* | 1.986(0.691–5.708) | 0.203 |
Gender (Male vs. Female) | 0.997(0.734–1.355) | 0.986 | 1.040 (0.726–1.491) | 0.830 |
Breslow depth value (≥3 mm vs. <3 mm) | 0.370(0.265–0.518) | <0.000* | 0.509(0.302–0.859) | 0.011* |
Five-miRNA signature (high risk vs. low risk) | 0.613(0.456–0.823) | 0.001* | 0.605(0.424–0.863) | 0.006* |
Notes.
P < 0.05 was considered statistically significant.